- Home
- NXPI vs CI Comparison
NXPI vs CI Comparison
Compare NXPI & CI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NXPI | CI |
|---|---|---|
| Founded | 2006 | 1792 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.0B | 79.0B |
| IPO Year | 2007 | 2018 |
Fundamental Metrics
Financial Performance| Metric | NXPI | CI |
|---|---|---|
| Price | $244.86 | $287.11 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 21 | 15 |
| Target Price | $285.76 | ★ $349.00 |
| AVG Volume (30 Days) | ★ 3.8M | 1.6M |
| Earning Date | 04-28-2026 | 04-30-2026 |
| Dividend Yield | 1.40% | ★ 2.13% |
| EPS Growth | N/A | ★ 83.00 |
| EPS | 4.43 | ★ 6.26 |
| Revenue | $12,269,000,000.00 | ★ $274,900,000,000.00 |
| Revenue This Year | $12.56 | $5.91 |
| Revenue Next Year | $10.17 | $5.92 |
| P/E Ratio | $54.40 | ★ $47.36 |
| Revenue Growth | N/A | ★ 11.24 |
| 52 Week Low | $183.00 | $239.51 |
| 52 Week High | $339.95 | $315.47 |
Technical Indicators
Market Signals| Indicator | NXPI | CI |
|---|---|---|
| Relative Strength Index (RSI) | 30.63 | 55.73 |
| Support Level | $225.39 | $266.69 |
| Resistance Level | $247.41 | $306.70 |
| Average True Range (ATR) | 11.46 | 8.69 |
| MACD | -2.39 | 0.73 |
| Stochastic Oscillator | 3.61 | 66.25 |
Price Performance
Historical ComparisonAbout NXPI NXP Semiconductors N.V.
NXP Semiconductors is a leading supplier of high-performance mixed-signal products. The firm acquired Freescale Semiconductor in 2015 and now has significant market share in the automotive market, where it supplies microcontrollers and analog chips into automotive clusters, powertrains, infotainment systems, and radars. NXP Semiconductors also serves industrial and Internet of Things, mobile, and communications infrastructure.
About CI The Cigna Group
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.